Charles Schwab Investment Management Inc Emergent Bio Solutions Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,290,230 shares of EBS stock, worth $9.95 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,290,230
Previous 2,224,727
42.01%
Holding current value
$9.95 Million
Previous $18.6 Million
33.6%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding EBS
# of Institutions
172Shares Held
36.8MCall Options Held
336KPut Options Held
203K-
Black Rock Inc. New York, NY3.84MShares$29.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.2MShares$24.7 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.14MShares$16.5 Million0.01% of portfolio
-
State Street Corp Boston, MA1.96MShares$15.1 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.54MShares$11.9 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $384M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...